ANNUAL MSK SYMPOSIUM ON LYMPHOMA 2020This symposium will feature updated information on lymphoma...
Transcript of ANNUAL MSK SYMPOSIUM ON LYMPHOMA 2020This symposium will feature updated information on lymphoma...
5TH ANNUALMSK SYMPOSIUM ON
LYMPHOMA 2020
Memorial Sloan Kettering Cancer CenterZuckerman Research Center
May 2-3, 2020 // New York City
State-of-the-Art in Biology, Therapy, and Patient Care
This symposium will feature updated information on lymphoma biology, diagnosis, immunology, and genetics, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphomas. Faculty will review the current standard of care and present their own perspectives on how they treat various types of lymphomas. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biologic and genetic biomarkers into clinical practice and clinical trials.
The target audience for this symposium includes medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma.
Special Luncheon Events (space is limited)
Participants are invited to attend the special luncheon events, one hosted by the Adult BMT Service and the other hosted by the Myeloma Service. RSVP for the luncheons during course registration (space is limited and we do encourage early registration).
Adult BMT Luncheon (Saturday, 12:00-1:00 pm)The Road to Cure in Relapsed and Refractory DLBCL: via CAR19 or Other Modes of Transplantation?
Myeloma Luncheon (Sunday, 12:00-1:00 pm) Multiple Myeloma in 2020: Monoclonal Antibodies, CAR T cells, Genomic Profiling, and MRD Tracking
Complimentary Networking Reception
Participants are invited to a complimentary networking reception on Saturday evening from 5:30-6:30 pm, which will provide an opportunity to meet and interact with the course faculty and get to know other symposium attendees. RSVP for the reception during registration.
OVERVIEW
1 | 5th Annual MSK Symposium on Lymphoma 5th Annual MSK Symposium on Lymphoma | 2
Anas Younes, MD
MSK Symposium Chair
MSK Organizing Committee
Ahmet Dogan, MD, PhD
Joachim Yahalom, MD, FACR
Hans-Guido Wendel, MD
Andrew D. Zelenetz, MD, PhD
Live Simulcast Option Available
Unable to attend this course in person? We are pleased to offer a live simulcast option for this symposium. CME credit is offered for the live simulcast and pre-registration is required. We do hope you will attend in person but understand that can sometimes be a challenge, so we are happy to offer the live simulcast as an option.
Please note that the live simulcast is only available to non-MSK attendees. MSK employees are welcome to register to attend this course in person.
Andrew M. Intlekofer, MD, PhD
Ariela Noy, MD
Christian Buske, MDCCC Ulm/University Hospital Ulm Ulm, Germany
Bjoern Chapuy, MD, PhDUniversity of GöttingenGöttingen, Germany
Riccardo Dalla-Favera, MDColumbia University New York, NY
Martin Dreyling, MD, PhDUniversity of MunichMunich, Germany
John Gribben, MD, DSc, FRCP, FRCPath, FMedSciQueen Mary’s School of MedicineUniversity of LondonLondon, United Kingdom
Michael Hallek, MDClinic I of Internal MedicineUniversity Hospital Cologne Cologne, Germany
Tim Illidge, BSc, PhD, FRCPE, FRCR, FRCPathUniversity of Manchester Manchester, United Kingdom
Ari M. Melnick, MDWeill Cornell Medical College New York, NY
Invited Faculty
Markus Müschen, MD, PhDCity of Hope National Medical CenterDuarte, CA
Michael Reth, PhDUniversity of Freiburg Freiburg, Germany
Jean-Ehrland Ricci, PhDINSERM Nice, France
Davide Rossi, MD, PhDInstitute of Southern Switzerland IOSIBellinzona, Switzerland
Gilles Salles, MD, PhDUniversity of LyonLyon, France
Bouthaina Shbib Dabaja, MDMD Anderson Cancer CenterHouston, TX
Karin Tarte, PhDRennes University HospitalRennes, France
Chi Van Dang, MD, PhDUniversity of PennsylvaniaPhiladelphia, PA
Catherine Wu, MDDana-Farber Cancer InstituteBoston, MA
Christian Grommes, MD Steven Horwitz, MDBrandon Imber, MD Anthony Mato, MD, MSCEDavid J. Straus, MDDana Tsui, PhD
MSK Faculty
7:30 am Registration and Breakfast
8:00 am Welcome and Opening Remarks Anas Younes, MD
PathologyMODERATOR: Ahmet Dogan, MD, PhD
8:05 am Pathology Classification Ahmet Dogan, MD, PhD
8:40 am Introduction and Clinical Application of ctDNA Dana Tsui, PhD
9:10 am Discussion
Diffuse Large B Cell LymphomaMODERATOR: Anas Younes, MD
9:30 am Molecular Pathogenesis Riccardo Dalla-Favera, MD
10:00 am Molecular Classification Bjoern Chapuy, MD, PhD
10:30 am The Tale of Ramos and the Function of CD20 Michael Reth, PhD
11:00 am Evolving Frontline and Salvage Therapy of DLBCL Anas Younes, MD
11:30 am Discussion
12:00 pm Lunch Break
Optional Adult BMT Luncheon* The Road to Cure in Relapsed and Refractory DLBCL: via CAR19 or Other Modes of Transplantation?
*Luncheon RSVP required (space is limited; early registration encourage).
Chronic Lymphocytic Leukemia (CLL)MODERATOR: Andrew D. Zelenetz, MD, PhD
1:00 pm Pathogenesis John Gribben, MD, DSc, FRCP, FRCPath, FMedSci
1:30 pm Current Management Michael Hallek, MD
2:00 pm Novel Treatment Approaches Andrew D. Zelenetz, MD, PhD
2:30 pm Real World Experience Anthony Mato, MD, MSCE
3:00 pm Discussion
3:20 pm Break
Follicular Lymphoma MODERATOR: Hans-Guido Wendel, MD
3:40 pm Epigenetics Ari M. Melnick, MD
4:00 pm Role of the Microenvironment Karin Tarte, PhD
4:20 pm Targeting Serine Metabolism in Follicular Lymphoma Hans-Guido Wendel, MD
4:40 pm Therapy of FL Gilles Salles, MD, PhD
5:10 pm Discussion
5:30 pm Adjourn
Networking ReceptionParticipants are invited to a complimentary networking reception from 5:30-6:30 pm in the lobby of Zuckerman Research Center. Hors d’oeuvres and refreshments will be served.
Saturday, May 2, 2020
FACULTY SCHEDULE
3 | 5th Annual MSK Symposium on Lymphoma 5th Annual MSK Symposium on Lymphoma | 4
Faculty DisclosureIt is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it provides as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity provided by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.
7:30 am Breakfast
Focus on Tumor MetabolismMODERATOR: Andrew Intlekofer, MD, PhD
8:00 am Introduction to Tumor Metabolism Andrew Intlekofer, MD, PhD
8:10 am Metabolic Control of T Cell Lymphoma Andrew Intlekofer, MD, PhD
8:30 am Metabolic Gatekeepers in B Cell Malignancies Markus Müschen, MD, PhD
8:50 am Metabolism and Lymphoma: From Basic to Translational Research
Jean-Ehrland Ricci, PhD
9:10 am Mitochondrial Reprogramming and Resistance to BCL2 Inhibition in Lymphoid Malignancies
Catherine Wu, MD
9:30 am TBA Chi Van Dang, MD, PhD
9:50 am Discussion
10:00 am Break
How I Treat (Session I)MODERATOR: David J. Straus, MD
10:20 am MCL Martin Dreyling, MD, PhD
10:50 am Marginal Zone: Molecular Pathogenesis and Treatment Approaches
Davide Rossi, MD, PhD
11:20 am Hodgkin Lymphoma David J. Straus, MD
11:50 am Discussion
12:00 pm Lunch Break
Optional Myeloma Luncheon Multiple Myeloma in 2020: Monoclonal Antibodies, CAR T cells, Genomic Profiling, and MRD Tracking
*Luncheon RSVP required (space is limited; early registration encourage).
Novel Approaches in Radiation TherapyMODERATOR: Joachim Yahalom, MD, FACR
1:00 pm Immunoradiotherapy Tim Illidge, BSc, PhD, FRCPE, FRCR, FRCPath
1:20 pm Radiation Therapy in the Era of CAR T cells Brandon Imber, MD
1:40 pm Proton Therapy in Lymphoma Bouthaina Shbib Dabaja, MD
2:00 pm Discussion
2:20 pm Break
How I Treat (Session II)MODERATOR: Ariela Noy, MD
2:40 pm Waldenstrom Christian Buske, MD
3:00 pm Burkitt Lymphoma and HIV Lymphoma Ariela Noy, MD
3:20 pm T Cell Lymphoma Steven Horwitz, MD
3:40 pm Primary CNS Lymphoma Christian Grommes, MD
4:00 pm Discussion
4:30 pm Closing Remarks Anas Younes, MD
4:45 pm Adjourn
5 | 5th Annual MSK Symposium on Lymphoma
Sunday, May 3, 2020 REGISTRATION
Registration Fees Early Rate* General
Physicians (MDs, PhDs and DOs) $350 $400
Nurses, PAs and Other Healthcare Professionals $150 $200
Residents and Fellows $100 $150
Industry Professionals** $650 $700
Live Simulcast*** $550 $600
*Early registration rates available through March 7, 2020.**Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.
***Please note that the live simulcast is only available to non-MSK employees. MSK employees are welcome to register to attend this course in person.
Register online:
mskcc.org/lymphomacourseCourse registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.
• MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course.
Symposium Location Zuckerman Research Center417 East 68th StreetNew York, NY
MSK has negotiated special rates and amenities at select hotels in Manhattan. For more information, visit: mskcc.org/lymphomacourse
5th Annual MSK Symposium on Lymphoma | 6
Accreditation
Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation StatementMSK designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
mskcc.org/lymphomacourse